Home › Funds › ORBIMED ADVISORS LLC › MBX

ORBIMED ADVISORS LLC position in MBX

MBX BIOSCIENCES INC COM · Health Care

ORBIMED ADVISORS LLC reported holding 3,428,736 shares of MBX (MBX BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$189.3M, representing 3.80% of its reported portfolio and ranking #4 among its reported holdings. ORBIMED ADVISORS LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)3.43M sh
Reported value held$189.27M
Portfolio Weight3.80%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's MBX position evolved

ORBIMED ADVISORS LLC first disclosed a stake in MBX in Q3 2024 at 3,812,215 shares (US$99.0M). The position peaked in Q2 2026 at 3,428,736 shares, worth US$189.3M. Across 8 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 3,428,736 shares valued at US$189.3M — a reduction of -209,151 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.81M $99.04M New
Q4 2024 3.81M $70.26M Hold
Q1 2025 4.00M $29.54M Add
Q2 2025 4.00M $45.67M Hold
Q3 2025 4.00M $70.05M Hold
Q4 2025 3.94M $124.12M Reduce
Q1 2026 3.64M $108.59M Reduce
Q2 2026 3.43M $189.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC COM) is a Health Care company. 73 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), Paradigm Biocapital Advisors LP (US$138.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held MBX?

ORBIMED ADVISORS LLC has disclosed MBX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is ORBIMED ADVISORS LLC's current position in MBX?

As of Q2 2026, ORBIMED ADVISORS LLC holds 3.43M shares of MBX (MBX BIOSCIENCES INC COM), valued at $189.27M, representing 3.80% of its reported portfolio and ranking #4.

Has ORBIMED ADVISORS LLC been buying or selling MBX?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in MBX. The position peaked in Q2 2026 at 3.43M shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, Paradigm Biocapital Advisors LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.